Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?

E Boel, J Selmer, HJ Flodgaard, T Jensen - Journal of Diabetes and its …, 1995 - Elsevier
Patients suffering from the severe complications associated with both insulin-(IDDM) and
noninsulin-dependent diabetes mellitus (NIDDM): nephropathy, retinopathy, neuropathy …
被引用次数：110 相关文章

[引用][C] Diabetic late complications; will aldose reductase inhibitors of advanced glycosylation endproduct formation hold promise?

E BOEL - J. Diab. Complications, 1995 - cir.nii.ac.jp
Diabetic late complications;will aldose reductase inhibitors of advanced glycosylation
endproduct formation hold promise? | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
[PDF] academia.edu

[PDF][PDF] Diabetic Late Complications: Will Aldose Reductase Inhibitors or Inhibitors of Advanced Glycosylation Endproduct Formation Hold Promise?

E Boel, J Selmer, HJ Flodgaard, T Jensen - academia.edu
Patients suffering from the severe complications associated with both insulin-(IDDM) and
noninsulin-dependent diabetes mellitus (NIDDM): nephropathy, retinopathy, neuropathy …

Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?

E Boel, J Selmer, HJ Flodgaard… - Journal of diabetes …, 1995 - pubmed.ncbi.nlm.nih.gov
Patients suffering from the severe complications associated with both insulin-(IDDM) and
non-insulin-dependent diabetes mellitus (NIDDM): nephropathy, retinopathy, neuropathy …

Diabetic Late Complications: Will Aldose Reductase Inhibitors or Inhibitors of Advanced Glycosylation Endproduct Formation Hold Promise?

E Boel, J Selmer, HJ Flodgaard, T Jensen - Journal of Diabetes and Its …, 1995 - infona.pl
Patients suffering from the severe complications associated with both insulin-(IDDM) and
non-insulin-dependent diabetes mellitus (NIDDM): nephropathy, retinopathy, neuropathy …

[引用][C] Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?

E BOEL, J SELMER, HJ FLODGAARD… - Journal of diabetes …, 1995 - pascal-francis.inist.fr
Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced
glycosylation endproduct formation hold promise? CNRS Inist Pascal-Francis CNRS Pascal …

Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?

E Boel, J Selmer, HJ Flodgaard… - Journal of Diabetes and its …, 1995 - europepmc.org
Patients suffering from the severe complications associated with both insulin-(IDDM) and
non-insulin-dependent diabetes mellitus (NIDDM): nephropathy, retinopathy, neuropathy …
[PDF] academia.edu

[PDF][PDF] Diabetic Late Complications: Will Aldose Reductase Inhibitors or Inhibitors of Advanced Glycosylation Endproduct Formation Hold Promise?

E Boel, J Selmer, HJ Flodgaard, T Jensen - academia.edu
Patients suffering from the severe complications associated with both insulin-(IDDM) and
noninsulin-dependent diabetes mellitus (NIDDM): nephropathy, retinopathy, neuropathy …

[引用][C] Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?

E BOEL, J SELMER, HJ FLODGAARD… - Journal of diabetes and its …, 1995 - Elsevier